9926:HKEXAkeso, Inc. Analysis
Data as of 2026-07-07 - not real-time
NT$49.70
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Shin Hai Gas trades just above its short‑term moving averages, with the 20‑day SMA sitting slightly below the current price and the 50‑day SMA offering modest support. Technical momentum is mildly positive as the MACD line sits above its signal line, while the RSI hovers in a neutral zone, suggesting limited upside pressure toward the nearby resistance level.
Fundamentally, the company commands a strong cash position, negligible debt and a generous dividend yield that ranks among the higher end of the utilities space. However, a discounted cash‑flow model points to a fair value well below the market price, indicating that the stock may be priced for optimism despite modest revenue growth. The defensive nature of the regulated gas sector, combined with a near‑zero beta and moderate price volatility, reinforces its profile as a stable, income‑focused investment.
Fundamentally, the company commands a strong cash position, negligible debt and a generous dividend yield that ranks among the higher end of the utilities space. However, a discounted cash‑flow model points to a fair value well below the market price, indicating that the stock may be priced for optimism despite modest revenue growth. The defensive nature of the regulated gas sector, combined with a near‑zero beta and moderate price volatility, reinforces its profile as a stable, income‑focused investment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD crossover
- Price near short‑term support levels
- High dividend yield offering immediate income
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong cash generation and low leverage
- Valuation above intrinsic estimate
- Stable regulated revenue stream
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend backed by solid cash flow
- Defensive utility exposure with low beta
- Limited growth offset by defensive earnings stability
Key Metrics & Analysis
Financial Health
Revenue Growth-1.00%
Profit Margin19.88%
P/E Ratio18.5
ROE11.38%
ROA3.11%
Debt/Equity0.17
P/B Ratio2.0
Op. Cash FlowNT$949.2M
Free Cash FlowNT$289.3M
Industry P/E20.8
Technical Analysis
TrendNeutral
RSI54.4
SupportNT$48.10
ResistanceNT$49.95
MA 20NT$49.44
MA 50NT$49.29
MA 200NT$49.72
MACDBullish
VolumeIncreasing
Fear & Greed Index93.63
Valuation
Fair ValueNT$39.60
GradeOvervalued
TypeValue
Dividend Yield4.23%
Risk Assessment
Beta-0.13
Volatility9.81%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.